BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17845979)

  • 1. [Gemcitabine and digestive carcinomas].
    Blanchard P; Huguet F; André T
    Bull Cancer; 2007; 94 Spec No Actualites():S104-15. PubMed ID: 17845979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of capecitabine in the management of tumors of the digestive system.
    Gennatas C; Michalaki V; Gennatas S
    Rev Recent Clin Trials; 2009 Jan; 4(1):1-11. PubMed ID: 19149758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy for biliary tract cancer in Japan.
    Okusaka T
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):51-3. PubMed ID: 12577234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
    Rocha Lima CM; Flores AM
    J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
    [No Abstract]   [Full Text] [Related]  

  • 7. [Systemic chemotherapy with gemcitabine for advanced biliary tract carcinoma].
    Nakamura N; Teramoto K; Arii S
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():534-8. PubMed ID: 16457320
    [No Abstract]   [Full Text] [Related]  

  • 8. Review of gemcitabine in biliary tract carcinoma.
    Scheithauer W
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):40-5. PubMed ID: 12577232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
    Conroy T; Desseigne F; Ychou M; Bouché O; Guimbaud R; Bécouarn Y; Adenis A; Raoul JL; Gourgou-Bourgade S; de la Fouchardière C; Bennouna J; Bachet JB; Khemissa-Akouz F; Péré-Vergé D; Delbaldo C; Assenat E; Chauffert B; Michel P; Montoto-Grillot C; Ducreux M; ;
    N Engl J Med; 2011 May; 364(19):1817-25. PubMed ID: 21561347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-surgical treatment for pancreatic cancer].
    Okusaka T; Ueno H; Ikeda M; Morizane C
    Nihon Shokakibyo Gakkai Zasshi; 2006 Apr; 103(4):391-7. PubMed ID: 16629457
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of oxaliplatin in the management of upper gastrointestinal tract malignancies.
    Scheithauer W; Van Cutsem E
    Colorectal Dis; 2003 Nov; 5 Suppl 3():36-44. PubMed ID: 23573559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A weekly 24-h infusion of high-dose 5-fluorouracil (5-FU)+leucovorin and bi-weekly cisplatin (CDDP) was active and well tolerated in patients with non-colon digestive carcinomas.
    Caroli-Bosc FX; Van Laethem JL; Michel P; Gay F; Hendlisz A; Forget F; Bleiberg H
    Eur J Cancer; 2001 Oct; 37(15):1828-32. PubMed ID: 11576835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibility of immunotherapy for biliary tract cancer: how do we prove efficacy? Introduction to a current ongoing phase I and randomized phase II study to evaluate the efficacy and safety of adding Wilms tumor 1 peptide vaccine to gemcitabine and cisplatin for the treatment of advanced biliary tract cancer (WT-BT trial).
    Okusaka T; Ueno M; Sato T; Heike Y
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):314-8. PubMed ID: 22273718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study.
    Tsavaris N; Kosmas C; Skopelitis H; Gouveris P; Kopterides P; Loukeris D; Sigala F; Zorbala-Sypsa A; Felekouras E; Papalambros E
    Invest New Drugs; 2005 Aug; 23(4):369-75. PubMed ID: 16012797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional chemotherapy of advanced pancreatic cancer.
    Giuliani F; Di Maio M; Colucci G; Perrone F
    Curr Drug Targets; 2012 Jun; 13(6):795-801. PubMed ID: 22458526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.
    Davis EJ; Griffith KA; Kim EJ; Ruch JM; McDonnell KJ; Zalupski MM
    Am J Clin Oncol; 2018 Feb; 41(2):128-132. PubMed ID: 26535993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gemcitabine and pancreatic cancer].
    Prost P; Ychou M; Azria D
    Bull Cancer; 2002 Aug; 89 Spec No():S91-5. PubMed ID: 12449037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer.
    Murad AM; Guimarães RC; Aragão BC; Rodrigues VH; Scalabrini-Neto AO; Padua CA; Moore FC
    Am J Clin Oncol; 2003 Apr; 26(2):151-4. PubMed ID: 12714886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent updates on the role of chemotherapy in pancreatic cancer.
    Burris HA
    Semin Oncol; 2005 Aug; 32(4 Suppl 6):S1-3. PubMed ID: 16143160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.